PT2356993T - Medicamento para a redução da colesterolemia e da trigliceridemia - Google Patents
Medicamento para a redução da colesterolemia e da trigliceridemiaInfo
- Publication number
- PT2356993T PT2356993T PT111523940T PT11152394T PT2356993T PT 2356993 T PT2356993 T PT 2356993T PT 111523940 T PT111523940 T PT 111523940T PT 11152394 T PT11152394 T PT 11152394T PT 2356993 T PT2356993 T PT 2356993T
- Authority
- PT
- Portugal
- Prior art keywords
- triglyceridemia
- cholesterolemia
- medicament
- reduction
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1050537A FR2955495B1 (fr) | 2010-01-27 | 2010-01-27 | Medicament pour la reduction de la cholesterolemie |
Publications (1)
Publication Number | Publication Date |
---|---|
PT2356993T true PT2356993T (pt) | 2017-09-29 |
Family
ID=42342822
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT111523940T PT2356993T (pt) | 2010-01-27 | 2011-01-27 | Medicamento para a redução da colesterolemia e da trigliceridemia |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP2356993B1 (pt) |
DK (1) | DK2356993T3 (pt) |
ES (1) | ES2640048T3 (pt) |
FR (1) | FR2955495B1 (pt) |
PL (1) | PL2356993T3 (pt) |
PT (1) | PT2356993T (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3092318A1 (en) * | 2012-09-20 | 2014-03-27 | Prothera, Inc. | Probiotic compositions and methods for the treatment of obesity and obesity-related conditions |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPS194902A0 (en) * | 2002-04-24 | 2002-06-06 | Atheromastat Pty Ltd | Compositions and methods for diagnosis and treatment of cardiovascular disorders |
EP2030623A1 (en) * | 2007-08-17 | 2009-03-04 | Nestec S.A. | Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria |
AP2010005247A0 (en) * | 2007-10-16 | 2010-06-30 | Exichol Sa | Composition for regulating lipid metabolism |
-
2010
- 2010-01-27 FR FR1050537A patent/FR2955495B1/fr active Active
-
2011
- 2011-01-27 DK DK11152394.0T patent/DK2356993T3/en active
- 2011-01-27 EP EP11152394.0A patent/EP2356993B1/fr active Active
- 2011-01-27 ES ES11152394.0T patent/ES2640048T3/es active Active
- 2011-01-27 PL PL11152394T patent/PL2356993T3/pl unknown
- 2011-01-27 PT PT111523940T patent/PT2356993T/pt unknown
Also Published As
Publication number | Publication date |
---|---|
DK2356993T3 (en) | 2017-10-02 |
EP2356993A1 (fr) | 2011-08-17 |
ES2640048T3 (es) | 2017-10-31 |
EP2356993B1 (fr) | 2017-06-21 |
PL2356993T3 (pl) | 2017-11-30 |
FR2955495B1 (fr) | 2012-05-11 |
FR2955495A1 (fr) | 2011-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS2100032I1 (hu) | Helyettesített 5-fluor-1H-pirazolopiridin-származékok és alkalmazásuk | |
HK1187049A1 (en) | Bisaryl-bonded aryltriazolones and use thereof | |
HRP20151041T1 (hr) | Šprica i spremnik s dvostrukom komorom i šprica napunjena aripiprazolom | |
EP2542086A4 (en) | COMPOUNDS AND ITS THERAPEUTIC USE | |
TWM391262U (en) | Hinge and interference member of the same | |
GB201011411D0 (en) | Therapeutic compounds and their use | |
HK1184779A1 (en) | Novel compound and medical use thereof | |
IL223707A0 (en) | N-hydroxyformamide derivative and medicament containing same | |
EP2615094A4 (en) | SESTERTERPEN COMPOUNDS AND THEIR USE | |
PL2356993T3 (pl) | Lek do zmniejszenia cholesterolemii i triglicerydemii | |
PL2621441T3 (pl) | Układ zapięcia pieluchy | |
GB201020357D0 (en) | Compounds and methods of making the same | |
GB2490473B (en) | Process for the preparation of hydrocolloid particulates and use thereof | |
EP2638220A4 (en) | CLAMP AND MOUNT OF THIS BRACKET | |
AU2012903508A0 (en) | Breast-protective orthosis and use thereof | |
EP2657236A4 (en) | NEW 2-ALKYNYL-N9-PROPARGYLADENINE AND ITS MEDICAL USE | |
IL226234A0 (en) | Nucleons, ribocapsids and methods@לייצורם | |
GB201002451D0 (en) | Pharmaceutical comopitions and devices | |
PL391702A1 (pl) | Sposób otrzymywania 5-hydroksykreatyniny i N-metyloguanidyny | |
GB201001370D0 (en) | New compounds and medical uses | |
GB201001364D0 (en) | New compounds and medical uses | |
GB201001376D0 (en) | New compounds and medical uses | |
GB201001383D0 (en) | New compounds and medical uses | |
AU2010904801A0 (en) | Seleno-Compounds and Therapeutic Uses Thereof | |
PL390856A1 (pl) | Zastosowanie melatoniny do wytwarzania preparatów ochronnych skóry |